MediScience Espoir Inc. · Kawasaki, Japan · Est. 2004

Home / News

News

Product launches, patents, manufacturing and company milestones.

  • Product

    New HT Silver developed and launched.

  • Ingredient

    WOX400 launched as a cosmetic and food ingredient.

  • Company

    Certified “Kawasaki Eruboshi” by the City of Kawasaki for advancing women in the workplace.

  • Product

    WOX Gummy Cap, a chewable form of WOX technology, launched in Japan.

  • Manufacturing

    Daisen Factory in Tottori Prefecture begins operation. WOX® 8 L and a dedicated dispenser launched.

  • Ingredient

    Oxygen liposome developed and launched as a cosmetic ingredient.

  • Manufacturing

    WOX® manufacturing unit No. 4 selected for a Kanagawa Prefecture productivity grant.

  • Patent

    Substance patent for oxygen clathrate hydrate granted in Japan (JP 7087235).

  • Patent

    Substance patent granted in the United States (US 10,913,037 B2), followed by China (ZL 2015 8 0071029.1).

United States patent certificate for oxygen clathrate
U.S. patent certificate, February 2021.
Announcement · February 2021

WOX® obtains a substance patent in the United States.

A substance patent protects a new chemical substance itself. Oxygen clathrate hydrate is a compound in which water molecules form a cage that holds a guest molecule, here oxygen.

Title of invention
Oxygen clathrate and oxygen solution containing the same
Patent number
US 10,913,037 B2
First named inventor
Takaaki Matsumoto
Company video

MediScience Espoir in five minutes.

An introduction to our company, our technology and WOX®.

Looking for a technology partner in Japan?

Licensing, OEM and ingredient supply for partners worldwide.

Contact our team →